{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:31:20Z","timestamp":1757626280727,"version":"3.44.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study was supported through an Operating Grant from the Canadian Institutes of Health Research and the Ontario Ministry of Health and Long-Term Care."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Increasingly, services for the management of substance use disorders have been developed or adapted for remote delivery. Limited research has investigated service user experience of these services. We undertook a qualitative sub-study, embedded within a pilot feasibility study of remote symptom-triggered alcohol withdrawal management, to better understand the experiences of participants. Our aim was to determine the acceptability of the intervention and refine intervention procedures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Eligible participants were enrolled in the parent study and completed at least one day of telemedicine-delivered symptom-triggered alcohol withdrawal management. Individuals were adults with alcohol use disorder recruited using intensity sampling. Participants completed an audio-recorded, semi-structured interview. Thematic analysis was conducted using Braun and Clarke interpretive methodology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Fourteen individuals were enrolled in the study. Six themes were identified: benefits of being in the home environment, technological tensions, intervention-specific feedback, personal motivations for participation, post-program achievements and changes and navigating the \u2018system\u2019. Participants identified numerous benefits of being in the home environment including: increased comfort, privacy and security, normalizing abstinence in the home, flexibility to engage in other tasks, and the convenience of not travelling. Intervention-specific feedback included positive aspects of the intervention (interactions with staff, accountability, counselling, use of medication), areas for improvement (preparation, scheduling, medication logistics, and aftercare), and the meaning and role of having a support person available during treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Participants found remote alcohol withdrawal management to be satisfactory and associated with several benefits including increased comfort, privacy, normalizing abstinence in the home, flexibility and convenience. They also provided important feedback for refinement of the intervention. Findings suggest that remote alcohol withdrawal management could play an important role in improving access to medical management of alcohol withdrawal, particularly in rural, remote or underserved areas.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13722-025-00585-8","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T06:51:49Z","timestamp":1755067909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cIt beats the hell out of going to a hospital\u201d: service user experiences of telemedicine-based symptom-triggered alcohol withdrawal management"],"prefix":"10.1186","volume":"20","author":[{"given":"Nikki","family":"Bozinoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke Bin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Ngoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gordezky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian S.","family":"Hendershot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"LaFleur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena C.","family":"Quilty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor M.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara Marie","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"585_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsat.2019.03.007","volume":"101","author":"LA Lin","year":"2019","unstructured":"Lin LA, Casteel D, Shigekawa E, Weyrich MS, Roby DH, McMenamin SB. Telemedicine-delivered treatment interventions for substance use disorders: A systematic review. J Subst Abuse Treat. 2019;101:38\u201349.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"585_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5498\/wjp.v6.i2.269","volume":"6","author":"S Hubley","year":"2016","unstructured":"Hubley S, Lynch SB, Schneck C, Thomas M, Shore J. Review of key telepsychiatry outcomes. World J Psychiatry. 2016;6(2):269\u201382.","journal-title":"World J Psychiatry"},{"issue":"5","key":"585_CR3","doi-asserted-by":"publisher","first-page":"e35159","DOI":"10.2196\/35159","volume":"9","author":"TJ Philippe","year":"2022","unstructured":"Philippe TJ, Sikder N, Jackson A, Koblanski ME, Liow E, Pilarinos A, et al. Digital health interventions for delivery of mental health care: systematic and comprehensive Meta-Review. JMIR Ment Health. 2022;9(5):e35159.","journal-title":"JMIR Ment Health"},{"issue":"5","key":"585_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1176\/appi.ps.202100088","volume":"73","author":"TL Mark","year":"2022","unstructured":"Mark TL, Treiman K, Padwa H, Henretty K, Tzeng J, Gilbert M. Addiction treatment and telehealth: review of efficacy and provider insights during the COVID-19 pandemic. Psychiatr Serv. 2022;73(5):484\u201391.","journal-title":"Psychiatr Serv"},{"issue":"2","key":"585_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40429-023-00480-9","volume":"10","author":"N Fast","year":"2023","unstructured":"Fast N, van Kessel R, Humphreys K, Ward NF, Roman-Urrestarazu A. The evolution of telepsychiatry for substance use disorders during COVID-19: a narrative review. Curr Addict Rep. 2023;10(2):187\u201397.","journal-title":"Curr Addict Rep"},{"issue":"6","key":"585_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/ADM.0000000000001006","volume":"16","author":"JL Sousa","year":"2022","unstructured":"Sousa JL, Raja P, Huskamp HA, Mehrotra A, Busch AB, Barnett ML, et al. Perspectives of patients receiving telemedicine services for opioid use disorder treatment: A qualitative analysis of user experiences. J Addict Med. 2022;16(6):702\u20138.","journal-title":"J Addict Med"},{"issue":"1","key":"585_CR7","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1080\/08897077.2022.2060447","volume":"43","author":"R Lockard","year":"2022","unstructured":"Lockard R, Priest KC, Gregg J, Buchheit BM. A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19. Subst Abus. 2022;43(1):1150\u20137.","journal-title":"Subst Abus"},{"issue":"7","key":"585_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_167_23","volume":"65","author":"A Ghosh","year":"2023","unstructured":"Ghosh A, Mahintamani T, Aswathy PV, Basu D, Mattoo SK, Subodh BN, et al. Service users\u2019 perception and attitude toward telemedicine-based treatment for substance use disorders: A qualitative study from India. Indian J Psychiatry. 2023;65(7):774\u201384.","journal-title":"Indian J Psychiatry"},{"issue":"7","key":"585_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/1357633X0501100701","volume":"11","author":"BC Frueh","year":"2005","unstructured":"Frueh BC, Henderson S, Myrick H. Telehealth service delivery for persons with alcoholism. J Telemed Telecare. 2005;11(7):372\u20135.","journal-title":"J Telemed Telecare"},{"issue":"6","key":"585_CR10","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s11606-019-04899-7","volume":"34","author":"JL Holleck","year":"2019","unstructured":"Holleck JL, Merchant N, Gunderson CG. Symptom-Triggered therapy for alcohol withdrawal syndrome: a systematic review and Meta-analysis of randomized controlled trials. J Gen Intern Med. 2019;34(6):1018\u201324.","journal-title":"J Gen Intern Med"},{"key":"585_CR11","doi-asserted-by":"crossref","unstructured":"Sloan ME, Ngoy A, Xiao KB, Barker B, Buckley L, Fodor M et al. Symptom-Triggered alcohol withdrawal management delivered over telemedicine. J Addict Med. 2025.","DOI":"10.1097\/ADM.0000000000001491"},{"issue":"12","key":"585_CR12","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1111\/add.14777","volume":"114","author":"L Maher","year":"2019","unstructured":"Maher L, Neale J. Adding quality to quantity in randomized controlled trials of addiction prevention and treatment: a new framework to facilitate the integration of qualitative research. Addiction. 2019;114(12):2257\u201366.","journal-title":"Addiction"},{"key":"585_CR13","unstructured":"Patton MQ. Designing qualitative studies. Qualitative Res Evaluation Methods. 2002;3:230\u201346."},{"issue":"4","key":"585_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1049732316665344","volume":"27","author":"MM Hennink","year":"2017","unstructured":"Hennink MM, Kaiser BN, Marconi VC. Code saturation versus meaning saturation: how many interviews are enough?? Qual Health Res. 2017;27(4):591\u2013608.","journal-title":"Qual Health Res"},{"issue":"2","key":"585_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"issue":"1","key":"585_CR16","doi-asserted-by":"publisher","first-page":"160940691773384","DOI":"10.1177\/1609406917733847","volume":"16","author":"LS Nowell","year":"2017","unstructured":"Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to Meet the trustworthiness criteria. Int J Qualitative Methods. 2017;16(1):1609406917733847.","journal-title":"Int J Qualitative Methods"},{"issue":"6","key":"585_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"7","key":"585_CR18","doi-asserted-by":"publisher","first-page":"e26187","DOI":"10.2196\/26187","volume":"8","author":"R Mazziotti","year":"2021","unstructured":"Mazziotti R, Rutigliano G. Tele-Mental health for reaching out to patients in a time of pandemic: provider survey and Meta-analysis of patient satisfaction. JMIR Ment Health. 2021;8(7):e26187.","journal-title":"JMIR Ment Health"},{"issue":"2","key":"585_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/ADT.0000000000000103","volume":"16","author":"K Tarp","year":"2017","unstructured":"Tarp K, Mejldal A, Nielsen AS. Patient satisfaction with Videoconferencing-based treatment for alcohol use disorders. Addict Disord their Treat. 2017;16(2):70\u20139.","journal-title":"Addict Disord their Treat"},{"issue":"1","key":"585_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.17140\/PCSOJ-5-145","volume":"5","author":"D Hilty","year":"2019","unstructured":"Hilty D, Randhawa K, Maheu M, McKean A, Pantera R. Therapeutic relationship of telepsychiatry and telebehavioral health: ideas from research on telepresence, virtual reality and augmented reality. Psychol Cogn Sci Open J. 2019;5(1):14\u201329.","journal-title":"Psychol Cogn Sci Open J"},{"key":"585_CR21","doi-asserted-by":"publisher","first-page":"e47008","DOI":"10.2196\/47008","volume":"7","author":"TN Officer","year":"2023","unstructured":"Officer TN, Tait M, McBride-Henry K, Burnet L, Werkmeister BJ. Mental health client experiences of telehealth in Aotearoa new Zealand during the COVID-19 pandemic: lessons and implications. JMIR Form Res. 2023;7:e47008.","journal-title":"JMIR Form Res"},{"issue":"6","key":"585_CR22","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/1467-9566.13100","volume":"42","author":"D Ivanova","year":"2020","unstructured":"Ivanova D. Post-place care: disrupting place-care ontologies. Sociol Health Illn. 2020;42(6):1296\u2013311.","journal-title":"Sociol Health Illn"},{"issue":"1","key":"585_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0306312711431817","volume":"42","author":"N Oudshoorn","year":"2012","unstructured":"Oudshoorn N. How places matter: Telecare technologies and the changing Spatial dimensions of healthcare. Soc Stud Sci. 2012;42(1):121\u201342.","journal-title":"Soc Stud Sci"},{"key":"585_CR24","unstructured":"Canadian Guideline for the Clinical Management of High-Risk Drinking and Alcohol Use Disorder. Canadian Research Initiative in Substance Misuse.; 2023."},{"issue":"3S Suppl 1","key":"585_CR25","first-page":"1","volume":"14","author":"J Wong","year":"2020","unstructured":"Wong J, Saver B, Scanlan JM, Gianutsos LP, Bhakta Y, Walsh J, et al. The ASAM clinical practice guideline on alcohol withdrawal management. J Addict Med. 2020;14(3S Suppl 1):1\u201372.","journal-title":"J Addict Med"},{"issue":"12","key":"585_CR26","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/S0277-9536(00)00305-1","volume":"52","author":"C May","year":"2001","unstructured":"May C, Gask L, Atkinson T, Ellis N, Mair F, Esmail A. Resisting and promoting new technologies in clinical practice: the case of telepsychiatry. Soc Sci Med. 2001;52(12):1889\u2013901.","journal-title":"Soc Sci Med"},{"issue":"Suppl 1","key":"585_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/1467-9566.12811","volume":"41","author":"M Pickersgill","year":"2019","unstructured":"Pickersgill M. Digitising psychiatry? Sociotechnical expectations, performative nominalism and biomedical virtue in (digital) psychiatric praxis. Sociol Health Illn. 2019;41(Suppl 1):16\u201330.","journal-title":"Sociol Health Illn"},{"issue":"Suppl 1","key":"585_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1467-9566.12898","volume":"41","author":"F Henwood","year":"2019","unstructured":"Henwood F, Marent B. Understanding digital health: productive tensions at the intersection of sociology of health and science and technology studies. Sociol Health Illn. 2019;41(Suppl 1):1\u201315.","journal-title":"Sociol Health Illn"},{"issue":"1","key":"585_CR29","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1186\/s12889-021-12104-w","volume":"21","author":"C Russell","year":"2021","unstructured":"Russell C, Ali F, Nafeh F, LeBlanc S, Imtiaz S, Elton-Marshall T, et al. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in ontario, Canada. BMC Public Health. 2021;21(1):2021.","journal-title":"BMC Public Health"},{"issue":"1","key":"585_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13011-023-00586-3","volume":"18","author":"F Ali","year":"2023","unstructured":"Ali F, Law J, Russell C, Bozinoff N, Rush B. An environmental scan of residential treatment service provision in Ontario. Subst Abuse Treat Prev Policy. 2023;18(1):73.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"585_CR31","first-page":"117822182097698","volume":"15","author":"M Stanojlovi\u0107","year":"2021","unstructured":"Stanojlovi\u0107 M, Davidson L. Targeting the barriers in the substance use disorder continuum of care with peer recovery support. Subst Abuse. 2021;15:1178221820976988.","journal-title":"Subst Abuse"},{"issue":"4","key":"585_CR32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/ADM.0000000000000399","volume":"12","author":"BJH Yarborough","year":"2018","unstructured":"Yarborough BJH, Chi FW, Green CA, Hinman A, Mertens J, Beck A, et al. Patient and system characteristics associated with performance on the HEDIS measures of alcohol and other drug treatment initiation and engagement. J Addict Med. 2018;12(4):278\u201386.","journal-title":"J Addict Med"},{"key":"585_CR33","doi-asserted-by":"crossref","unstructured":"Webb L, Ralphs R, Wright S, Dance C. Tackling hospital service burden of alcohol dependence in england: A service evaluation of alcohol care teams (ACTs) and care pathways for integrated care. Drugs: Educ Prev Policy. 2024:1\u201312.","DOI":"10.1080\/09687637.2024.2409841"},{"issue":"19","key":"585_CR34","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1001\/jama.299.19.2319","volume":"299","author":"D Dougherty","year":"2008","unstructured":"Dougherty D, Conway PH. The 3T\u2019s road map to transform US health care: the how of high-quality care. JAMA. 2008;299(19):2319\u201321.","journal-title":"JAMA"},{"issue":"4","key":"585_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jsat.2008.08.004","volume":"36","author":"BR Garner","year":"2009","unstructured":"Garner BR. Research on the diffusion of evidence-based treatments within substance abuse treatment: a systematic review. J Subst Abuse Treat. 2009;36(4):376\u201399.","journal-title":"J Subst Abuse Treat"},{"issue":"Suppl 1","key":"585_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/1467-9566.12980","volume":"41","author":"E Rich","year":"2019","unstructured":"Rich E, Miah A, Lewis S. Is digital health care more equitable? The framing of health inequalities within england\u2019s digital health policy 2010\u20132017. Sociol Health Illn. 2019;41(Suppl 1):31\u201349.","journal-title":"Sociol Health Illn"},{"key":"585_CR37","doi-asserted-by":"crossref","unstructured":"Kleinman RA, Bozinoff N. Access to telephone and Internet-Based telemedicine in Canadian households. Can J Psychiatry 68. United States2023. pp. 623\u20136.","DOI":"10.1177\/07067437231159348"},{"issue":"4","key":"585_CR38","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/10550887.2022.2035166","volume":"40","author":"S Delisle-Reda","year":"2022","unstructured":"Delisle-Reda S, Bruneau J, Martel-Laferri\u00e8re V. Telehealth for people who inject drugs: an acceptable method of treatment but challenging to access. J Addict Dis. 2022;40(4):514\u20137.","journal-title":"J Addict Dis"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00585-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-025-00585-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00585-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:25:03Z","timestamp":1757453103000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-025-00585-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1186\/s13722-025-00585-8","relation":{},"ISSN":["1940-0640"],"issn-type":[{"type":"electronic","value":"1940-0640"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author Bernard Le Foll name in citation details has been corrected from Foll BL to Le Foll B.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Bozinoff has received salary support from US National Institute on Drug Abuse (NIDA) grant R25-DA037756, unrelated to this work. She reports research grant funding from the Academic Health Sciences Innovation Fund, Womenmind, Canadian Institutes of Health Research (CIHR), Department of Family and Community Medicine\u2013University of Toronto, and the Canadian College of Family Physicians. She has received honoraria for continuing professional development work from the Ontario College of Family Physicians and CAMH Education, unrelated to this work. Dr. Sloan has received research support from the CIHR, Health Canada, the Ontario Ministry of Health and Long-Term Care, the CAMH Foundation, and the Academic Health Sciences Centre AFP Innovation Fund. Dr. Sloan is also supported in part by an Academic Scholar Award from the Department of Psychiatry, University of Toronto. Dr. Sloan has received travel support from the Society of Biological Psychiatry and the International Society for CNS Clinical Trials and Methodology. He has received an honorarium for giving a talk at the McGill University Health Centre. Dr. Le Foll has obtained funding from Indivior for a clinical trial sponsored by Indivior. Dr. Le Foll has in-kind donations of placebo edibles from Indiva. Dr. Le Foll has obtained industry funding from Canopy Growth Corporation (through research grants handled by the Centre for Addiction and Mental Health and the University of Toronto). He has participated in a session of a National Advisory Board Meeting (Emerging Trends BUP-XR) for Indivior Canada and is part of Steering Board for a clinical trial for Indivior. He is part of the Scientific Advisory Board of NFL Biosciences. He has been consultant for Shinogi, Changemark and ThirdBridge. He got travel support to attend an event by Bioprojet. He is supported by CAMH, Waypoint Centre for Mental Health Care, a clinician-scientist award from the department of Family and Community Medicine of the University of Toronto and a Chair in Addiction Psychiatry from the Department of Psychiatry of University of Toronto. Dr. Tang has received research support through the Brain & Behavior Research Foundation, CIHR (SCT\u2013 191291), the Physician Services Incorporated Foundation, the National Institute on Drug Abuse (R21DA061350), and the Labatt Family Network for Research on the Biology of Depression. Dr. Quilty has received research support from Wellcome Trust, CIHR, Health Canada, Ontario Brain Institute, Gambling Research Exchange Ontario and CAMH Foundation. The other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}